Literature DB >> 34014308

Error in Funding/Support.

.   

Abstract

Entities:  

Year:  2021        PMID: 34014308      PMCID: PMC8138686          DOI: 10.1001/jamaoncol.2021.1616

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  1 in total

1.  Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma.

Authors:  J Randall Patrinely; Rebecca Johnson; Aleigha R Lawless; Prachi Bhave; Amelia Sawyers; Maya Dimitrova; Hui Ling Yeoh; Marisa Palmeri; Fei Ye; Run Fan; Elizabeth J Davis; Suthee Rapisuwon; Georgina V Long; Andrew Haydon; Iman Osman; Janice M Mehnert; Matteo S Carlino; Ryan J Sullivan; Alexander M Menzies; Douglas B Johnson
Journal:  JAMA Oncol       Date:  2021-05-01       Impact factor: 31.777

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.